Invention Grant
- Patent Title: Parasite therapy
-
Application No.: US16564773Application Date: 2019-09-09
-
Publication No.: US11241447B2Publication Date: 2022-02-08
- Inventor: Thomas Julius Borody
- Applicant: Thomas Julius Borody
- Applicant Address: AU Sydney
- Assignee: Thomas Julius Borody
- Current Assignee: Thomas Julius Borody
- Current Assignee Address: AU Sydney
- Agency: Greer, Burns & Crain, Ltd.
- Agent Gregory P. Einhorn
- Priority: AU2009905150 20091022
- Main IPC: A61K31/65
- IPC: A61K31/65 ; A61K31/4704 ; A61K31/4174 ; A61K31/341 ; A61K31/4164 ; A61K31/422 ; A61K31/426 ; A61K31/496 ; A61K31/505 ; A61K45/06 ; A61K31/42 ; A61K31/47

Abstract:
There is disclosed herein a composition for treating extracellular parasitic infections, the composition comprising one or more of the following combinations: at least one quinolone or fluoroquinolone together with at least one tetracycline, iodoquinol, an azole or imidazole; or at least two agents selected from the group consisting of iodoquinol, thiazolidones, tetracycline, nitroimidazoles, cotrimoxazole and diloxanide furoate.
There is also disclosed herein a method for treating extracellular parasitic infections in a vertebrate in need of said treatment, wherein said treatment comprises administering to said vertebrate a therapeutically effective amount of (i) a composition comprising a quinolone or fluoroquinolone together with a pharmaceutically acceptable carrier or (ii) a composition of the invention or (iii) a combination of at least one quinolone or fluoroquinolone optionally together with at least one tetracycline, is iodoquinol, an azole or imidazole; or (iv) a combination of at least two agents selected from the group consisting of iodoquinol, thiazolidones, tetracycline, nitroimidazoles, cotrimoxazole and diloxanide furoate.
There is also disclosed herein a method for treating extracellular parasitic infections in a vertebrate in need of said treatment, wherein said treatment comprises administering to said vertebrate a therapeutically effective amount of (i) a composition comprising a quinolone or fluoroquinolone together with a pharmaceutically acceptable carrier or (ii) a composition of the invention or (iii) a combination of at least one quinolone or fluoroquinolone optionally together with at least one tetracycline, is iodoquinol, an azole or imidazole; or (iv) a combination of at least two agents selected from the group consisting of iodoquinol, thiazolidones, tetracycline, nitroimidazoles, cotrimoxazole and diloxanide furoate.
Public/Granted literature
- US20200069705A1 NOVEL PARASITE THERAPY Public/Granted day:2020-03-05
Information query